Related Experiment Video
Updated: Feb 5, 2026
Author Spotlight: Developing Innovative Therapeutic Strategies for Hemorrhagic Shock Research
Published on: March 22, 2024
Blood purification by nonselective hemoadsorption prevents death after traumatic brain injury and hemorrhagic shock
Todd O McKinley1, Zhigang Lei, Yannik Kalbas
1From the Departments of Orthopaedic Surgery, Anatomy and Cell Biology (T.O.M), Indiana University School of Medicine, IU Health Methodist Hospital; Department of Anatomy and Cell Biology (Z.L., Z.C.X), Indiana University School of Medicine, Indianapolis, Indiana; Universitätsspital Zürich (Y.K.), Zürich, Switzerland; Department of Anesthesiology (F.A.W.), Indiana University School of Medicine, Indianapolis, Indiana; GHM Institute of CNS Regeneration (Z.S.), Jinan University; Department of Pediatrics (F.W.), The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China; Department of Neurosurgery (R.B.R), Indiana University School of Medicine, Indianapolis, Indiana.
Background:
Patients who sustain traumatic brain injury (TBI) and concomitant hemorrhagic shock (HS) are at high risk of high-magnitude inflammation which can lead to poor outcomes and death. Blood purification by hemoadsorption (HA) offers an alternative intervention to reduce inflammation after injury. We tested the hypothesis that HA would reduce mortality in a rat model of TBI and HS.
Methods:
Male Sprague Dawley rats were subjected to a combined injury of a controlled cortical impact to their brain and pressure-controlled HS. Animals were subsequently instrumented with an extracorporeal blood circuit that passed through a cartridge for sham or experimental treatment. In experimental animals, the treatment cartridge was filled with proprietary beads (Cytosorbents, Monmouth Junction, NJ) that removed circulating molecules between 5 kDa and 60 kDa. Sham rats had equivalent circulation but no blood purification. Serial blood samples were analyzed with multiplex technology to quantify changes in a trauma-relevant panel of immunologic mediators. The primary outcome was survival to 96 hours postinjury.
Results:
Hemoadsorption improved survival from 47% in sham-treated rats to 86% in HA-treated rats. There were no treatment-related changes in histologic appearance. Hemoadsorption affected biomarker concentrations both during the treatment and over the ensuing 4 days after injury. Distinct changes in biomarker concentrations were also measured in survivor and nonsurvivor rats from the entire cohort of rats indicating biomarker patterns associated with survival and death after injury.
Conclusion:
Blood purification by nonselective HA is an effective intervention to prevent death in a combined TBI/HS rat model. Hemoadsorption changed circulating concentrations of multiple inmmunologically active mediators during the treatment time frame and after treatment. Hemoadsorption has been safely implemented in human patients with sepsis and may be a treatment option after injury.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
00:49The Blood-brain Barrier
01:16Shock Waves
When the source's speed approaches the speed of sound, constructive interference between successive wavefronts emitted by the source occurs immediately behind it. Initially, scientists believed that this constructive interference would result in such high...
02:59Cancer Prevention
Some...
01:20Traumatic Memory